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Abstract
In a search for the spirochetes responsible for
Lyme disease in Hong Kong, a sixty year old female,
with a clinical diagnosis of arthritis, was found to
have a rising antibody litre against Borrelia
burgdorferi by indirect immunofluorescent assay
(IFA).
This paper presents a brief review of Lyme
disease, its epidemiology, clinical features, diagnosis,
prevention and treatment, followed by a report of
this first case of Lyme disease in Hong Kong.
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History
For Americans, a discussion of the history of
Lyme borreliosis usually begins with the story of
two persevering women, Polly Murray and Judith
Mensch of Old Lyme, Connecticut. In the early
1970s, they were concerned about the occurrence
of arthritis in members of their families and in
families of the neighbouring towns of Lyme and
East Haddam. Severe headaches, skin lesions,
and subsequent recurring arthritic and neurologic
symptoms suggested to them that the physicians*
diagnosis of "juvenile rheumatoid arthritis" was
wrong. Their suspicion that something unusual
was happening was made known to the
Connecticut State Health Department, which
sought help from Dr. Allen Steere of the
Rheumatology Department at Yale University
Medical School. In October 1975, he started a
retrospective study that eventually led to the
description of Lyme arthritis,1 which was later
changed to Lyme disease,2 a new complex
multisystem disorder of unknown etiology.
Unknown to most Americans, however, is the
earliest reference to manifestations of what today
is known as Lyme borreliosis. In as early as 1909,
the Swedish physician, Dr. Arvid Afzelius,
reported an elderly woman who had a ringlike
skin lesion where she had been bitten by the
sheep tick, Ixodes ricinus? This characteristic
expanding skin lesion, erythema chronicum
migrans (ECM), has long been associated with
sheep tick bites,4-5 and with tick-borne
meningopolyneuritis in Europe.6'7 The association,
between Lyme Disease and Ixodid ticks is now
well recognized in Europe and the United States
"Address for correspondence:
370
Dr. I.J. Hodgkiss, Reader in Ecology & Biodiversity, The University of Hong Kong, Pokfulam Road, Hong
Kong.
Hong Kong Practitioner 17 (8) August 1995
of America;8 it is noted as the most prevalent tick-
borne illness in the coastal regions of North
America;9 and is of world-wide distribution,
including China.10'11 These syndromes are now
often subsumed under the name Lyme disease.
Although many theories have been proposed
to explain its etiology,12"17 the causative agent of
Lyme disease remained elusive until 1982, when
Burgdorferi and associates18 isolated the
spirochete that bears his name Borrelia burgdorferi
from Ixodes dammini in New York, and linked it
serologically to patients with Lyme disease. In the
following few years, numerous workers confirmed
the spirochete nature of the disease.19"23 Because
it is infectious in origin but inflammatory or
"rheumatic" in expression, Lyme disease, beyond
its intrinsic interest as a new nosologic entity,
presents a unique human model for an infectious
etiology of rheumatic disease.
during biting, or by infective tick faecal matter
that is deposited on the skin and rubbed into
the bite. The spiral organisms of medical
significance include Leptospira, which causes
human leptospirosis; Treponema, responsible for
the diseases known as treponematoses, such as
syphilis;24 and Borrelia, which causes relapsing
fever.25
Tick Vectors
Ticks are not insects, but related to spiders,
scorpions and mites, and placed in the class
Arachnida.26 There are two families of ticks, the
Ixodidae (hard-bodied ticks) and the Argasidae
(soft-bodied ticks), which differ morphologically
and behaviourally. Ixodes is one of the thirteen
genera of Ixodidae, and the principal vector of B.
burgdorferi worldwide.27
Epidemiology
Lyme disease has now been recognized as a
worldwide tickborne borreliosis of public health
importance. It has become the leading
vectorborne infectious disease in the United
States, with more than 40,000 cases reported to
the Centers for Disease Control in the 10-year
period 1982 to 1991.
The Hosts
The Ixodes vectors of B. burgdorferi that feed
on humans as incidental hosts also parasitize a
large number of small, medium and large wild and
domestic animals, including hundreds of species of
mammals, reptiles and birds.28"30
Global Distribution
The Pathogen
Borrelia burgdorferi, the causative agent of
Lyme disease,18 is a newly discovered
microaerophilic spirochete that is 2 to 20 \im
long but only 0.18 to 0.25 um wide, belonging to
the family Spirochaetaceae. B. burgdorferi occurs
mainly in wild white-footed mice, in deer, and in
ticks of the genus Ixodes. The ticks can transmit
the spirochete to humans by bites at any stage
of the tick's life cycle (i.e. larval, nymph and
adult). B. burgdorferi is injected into the skin of
an human victim either by infective tick saliva
Lyme disease is endemic in North America,
across Europe to Asia, including the British Isles,
western Europe and Russia (from the Baltic States
to the Pacific Coast),31'33 China and Japan. 1W1'34'35
Although not yet confirmed by isolation, the
disease has also been reported from Africa, South
America, Australia and India.33'36"38
Clinical Features
Lyme disease is an illness having protean
manifestations with symptoms that include:
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(1) an erythematous expanding red annular rash
with central clearing;
(2) fever, headache, stiff neck, nausea, and
vomiting;
(3) neurologic complications such as facial nerve
(Bell's) palsy and meningitis; and
(4) arthritis in about 50% of untreated patients.
These symptoms occur most frequently
from May to November, when ticks are active
and numerous, and people are engaged in many
outdoor activities. The most characteristic
feature of early Lyme disease is a skin rash,
often referred to as erythema chronicum
migrans (ECM), which appears shortly (3-32
days) after a bite from an infected tick. The
lesion typically expands almost uniformly from
the centre of the bite and is usually flat or
slightly indurated with central clearing and
reddening at the periphery. It is noteworthy,
however, that many Lyme disease victims do
not recall being bitten by a tick or do not
develop classic ECM. Indeed one third of the
patients may not develop ECM. On the other
hand, at various intervals after the initial rash,
some patients develop similar but smaller
multiple secondary annular skin lesions that last
for several weeks to months. In approximately
half of the patients, the first sign to appear is
a slowly expanding red rash at the site of the
bite. Beginning as a small flat or raised
lesion, the rash increases in diameter in a
circular pattern and over a period of weeks the
diameter may reach 10-15 inches. It has an
intense red border and a red centre resembling
a bull's eye. It can vary in shape and is
usually hot to touch. The initial tick bite may
be distinguished from a mosquito bite because
the latter itches, while a tick bite does not.39
Biopsy of these skin lesions reveals lymphocytic
and plasmacytic infiltrates. Various flulike
symptoms such as malaise, fever, headache, stiff
neck and arthralgias are often associated with
ECM. The spirochete eventually reaches the
brain, and within several weeks or months
about 15% of the patients develop meningitis,
which may be accompanied by excruciating
headaches and neck pain. There may be
abnormalities of the nervous system that last
for years, ranging from a mild tingling sensation
in the limbs to encephalomyelitis, partial
paralysis, or even mental deterioration. Within
several weeks after the onset of the disease,
approximately 8% of patients show cardiac
involvement indicated by heartbeat irregularity,
dizziness or shortness of breath. Within 2
weeks to 2 years after the beginning of the
disease, 80% of patients develop recurrent
arthritis, and eventually the knees or other
large joints may become swollen and painful.
Much of the damage to the body caused
by B. burgdorferi has been attributed to the
endotoxin in the outer membrane of the
spirochete. The endotoxin is believed to
stimulate macrophages to produce interleukin-1,
a regulator of the body's immune response.
Over-production of this regulator accounts for
the fever, skin rash and recurrent arthritis that
are characteristics of Lyme disease/0 The late
manifestations of Lyme disease may include
migratory and polyarticular arthritis, neurologic
and cardiac involvement with cranial nerve
palsies and radiculopathy, myocarditis and
arrhythmias. Lyme arthritis typically involves a
knee or other large joint. It may enter a
chronic phase, leading to destruction of bone
and joints if left untreated. Interestingly, Lyme
arthritis is less common in Europe than in the
USA, but neurologic complications are more
prevalent in Europe. Unique strain variations
expressing antigenic subtypes between European
and North American isolates of B. burgdorferi
probably explain these dissimilarities.
Diagnosis
Like syphilis, Lyme disease produces a
diverse number of clinical symptoms that can
be confused with many other disease entities.
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In many cases the clinical differential is often
complex resulting in heavy reliance on the
laboratory to provide diagnostic evidence.1'2-41-42
However, successful isolation and culture of B.
burgdorferi from skin lesions, blood and joint
and cerebrospinal fluid in suspected cases of
Lyme disease is rare,19'42 and most common
nonspecific laboratory tests are not helpful in
the differential diagnosis. Thus, serologic tests
provide the most important confirmatory
evidence of all stages of Lyme disease and may
be the only way of diagnosing atypical cases.
The most commonly used serologic tests are the
enzyme-linked immunosorbent assay (ELISA)
and indirect fluorescent-antibody assay (IFA)
which detect the specific antibody against B.
burgdorferi. Since antibodies to other
spirochetes, including Treponema pallidum, can
cross-react, differential diagnosis must be
undertaken using tests such as VDRL, TPHA
or RPR for all specimens showing a positive
reaction towards 8. burgdorferi.
In serum, specific IgM antibody titres
against B. burgdorferi usually reach a peak
between the third and sixth week after the
onset of disease; specific IgG antibody titres
rise more slowly and are generally highest
months later when arthritis is present.
On 19 October 1990, the CDC defined
case criteria for reportable disease.43 Lyme
disease is one of the diseases for which the
CDC established diagnostic clinical and
'laboratory criteria, as follows:
Clinical case definition - Erythema migrans,
or at least one late manifestation.
Laboratory criteria for diagnosis - isolation
of B. burgdorferi from clinical specimen, or
demonstration of diagnostic levels of IgM and
IgG antibodies to the spirochete in serum of
CSF, or significant change in IgM or IgG
antibody response to B. burgdorferi in paired
acute and convalescent-phase serum samples.
Treatment and Prevention
For early stage treatment, in order of
preference, oral tetracycline 250mg four times
a day, phenoxy-methyl penicillin 5OOmg four
times a day, or erythromycin 250mg four times
a day each for 10 to 20 days depending on the
response, is suggested.44
For meningitis and cranial or peripheral
neuropathies, intravenous penicillin G 20 million
U a day in six divided doses for 10 days is
effective therapy.43
For established Lyme arthritis, treatment
with intra-muscular benzathine penicillin 2.5
million U weekly for 3 weeks has been proven
to be successful.46 The affected joint should be
at rest, and accumulated fluid should be
removed by needle aspirations.
In vitro and in vivo susceptibility tests have
suggested that cefuroxime may be an effective
alternative therapy for Lyme disease.47
A few simple precautions will help reduce
possible exposure to Borrelia-infected ticks and
increase protection against Lyme disease.
These include wearing clothing that fully
protects the body and using repellents that
contain DEET (diethyltoluamide).48 People
should be made aware of the typical early
symptoms of infection, such as the characteristic
skin rash. The potential for human contact
with Ixodes ticks as a cause of occasional cases
of locally acquired spotted fever must not be
overlooked.
The Current Investigation
The incidence of Lyme disease has been
increasing considerably world-wide since 1975, but
it has never been documented in Hong Kong; and
the local situation regarding the disease is
unknown. In an attempt to investigate its
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occurrence in Hong Kong, since August 1992, a
survey of seroprevalence has been conducted in
patients with a clinical diagnosis of arthritis.
Blood samples of patients with a clinical
diagnosis of arthritis were collected from ten
different clinical laboratories in Hong Kong.
Whole blood specimens were centrifuged to obtain
sera for assay by indirect immunofluorescent
antibody (IFA) titre to Borrelia burgdorferi (Lyme-
spot IF, Ref. 75941 Bio Merieux, France); to
rheumatoid factor by agglutination of IgG coated
latex particles (RA80, Eiken Chemical, Japan);
and for antibodies against Treponema pallidum by
haemaglutination assay (TPHA, Fujirebio Inc.,
Japan) and the rapid plasma reagin card test
(RPR reditest, Biokit, Spain) following the
manufacturers' instructions. Other clinical and
laboratory data relating to the patients were also
collected and recorded as additional information.
For a potential patient to be defined as
positive for antibody to Borrelia burgdorferi, the
patient had to have a clinical diagnosis of arthritis,
a titre of 1:160 or greater for antibody to Borrelia
burgdorferi by indirect immunofluorescent antibody
(IFA), together with non-reactive results in the
remaining three assays, namely: (a) rheumatoid
factor (RA), (b) Treponema pallidum
haemaglutination assay (TPHA) as well as (c)
rapid plasma reagin (RPR).49
Case Report
In September 1992, a sixty year old female
patient recruited into the scheme mentioned
above with joint pains but no other symptoms of
arthritis was found to provide the results shown in
Table 1. The patient, who had travelled to the US
and Australia prior to seeking medical assistance,
had no previous history of skin lesions, etc. She
was later treated only with a two weeks course of
tetracycline 250mg q.i.d. and has since recovered
from her arthritis. The Borrelia burgdorferi
antibody titre (IFA) in her blood sample has
fallen from 1:320 to less than 1:160 nine months
after the treatment.
Table 1: Laboratory results of the first reported Lyme disease patient in Hong Kong
Test
Haemoglobin
Haematocrit
Red cell count
White cell count
ESR
Hepatitis B surface antigen
Uric Acid
Rheumatoid factor (RA)
TPHA
RPR
ANA
Borrelia burgdorferi
antibody titre (IFA)
First sample
Second sample (4 weeks apart)
Nine months after treatment
Result (unit)
13.8 (g/dL)
41(%)
4.4 (x 1012/L)
7.4 (x lO'/L)
35 (mm/hr)
Negative
45 (mg/L)
Negative
Negative
Non-reactive
Negative
Positive 1:160
Positive 1:320
Negative < 1:160
Reference range
12.0 - 16.0
36-48
4.0 - 5.0
5.0 - 10.0
0-20
Negative
25-75
Negative
Negative
Non-reactive
Negative
< 1:160
374
Discussion
The situation regarding Lyme disease in Hong
Kong is unclear. Although little is known about
the prevalence of the Ixodes ticks in this area,
there are several possible routes for Lyme disease
to gain entrance into Hong Kong.
1. Domestic animals, such as dogs and cats, are
found to be commonly infested by B.
burgdorferi carrying Ixodes ticks in endemic
areas.50"52 But pets imported into Hong Kong
are not known to have been de-ticked before
entrance. Ixodes ticks have been noted in
pets visiting local veterinarians.53
2. 49 species of birds have been found to be
infested by Ixodes ticks,29 and migrating birds
have already been suspected to be a route of
transmitting Lyme disease.54
3. Other than Ixodes ticks, possible transmission
of B. burgdorferi to humans by blood-sucking
insects such as fleas, mosquitoes and horse
flies has been reported.55136
4. The tremendously high volume of visitors, re-
immigrants, and travellers to and from
endemic areas each year has increased largely
the possibility of Lyme disease infection.
Like syphilis, Lyme disease has been called a
"great imitator" and is often difficult to diagnose
clinically. Less than one third of patients
presenting with ECM recall having been bitten by
ticks.57-58 Up to 50% of patients presenting with
Lyme arthritis may not recall the pathognomonic
ECM rash, flulike illness, or tick bite.59 The ECM
rash may be unrecognized or mistaken for another
annular dermatosis. Even in endemic areas of the
United States, such as eastern New York and
Hong Kong Practitioner 17 (8) August 1995
Connecticut, ECM went unrecognized by most
physicians until the early 1980s. In children, the
rash can be totally missed, when occurring in the
scalp area or other unobserved locations.2-60
In almost all clinical bacteriological
investigations, laboratory culture of causative
microorganisms is the prime tool for diagnosis;
however, for the screening of Lyme disease,
laboratory culture is not a practical option.
Isolation of Borrelia burgdorferi from blood serum,
joint fluid, cerebrospinal fluid, or tissue has
proven to be very difficult, if not impossible.
Successful positive cultures have been reported in
less than 5% of patients with otherwise proven
Lyme disease.22
Nearly all patients with Lyme arthritis have
antibodies to Borrelia burgdorferi detectable in
their sera. Antibody screening, therefore, remains
the most practical method for the detection of the
disease, pending the discovery of a better, more
reliable, faster methodology. False-positive
results, attributable to antibodies cross-reactive to
Borrelia burgdorferi, can also be seen, however, in
the serum of patients with other spirochetal
infections.57 Thus, confirmation of the diagnosis
of Lyme disease is only possible if results obtained
from the TPHA and RPR test are negative.
Routine laboratory testing is often not helpful
in the differential diagnosis of Lyme disease, since
some patients with Lyme disease may not have
laboratory abnormalities. Table 2 summarizes
laboratory findings during early Lyme disease,
where rheumatoid factor (RF) and ANA are
typically absent from the sera of Lyme disease
patients1 and, as can be seen from the results, less
than 60% showed any abnormality.
Table 2: Laboratory Findings in Early Lyme disease.23
Test Number of patients (%) with abnormal values* Median (range) of abnormal values
Haematocrit
Leukocytes >10 cells x lO'/mm3
ESR >20 mm/hr
IgM >250 mg/dL
37 (12)
24 (8)
166 (53)
104 (33)
35 (31 - 36)
12 (11 - 18)
35 (21 - 68)
310 (252 - 930)
'Total number of patients = 314
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The availability of laboratory tests and the
awareness of clinicians for ordering the test
therefore play the most important roles in
diagnosing the disease. However, most clinical
laboratories in Hong Kong do not carry out the
test for Lyme disease and it is not included in
"arthritis profile test". A recent survey of eight
local laboratories revealed that clinicians ordered
the test for Lyme disease less than once per year
per laboratory. It is not surprising that, although
Lyme disease is such a worldwide illness,
previously there has not been one single case
officially reported in Hong Kong.
It has been reported that Lyme disease is
endemic in China in the forested northeastern
regions, particularly in Hailongjiang and Jilin
Provinces;10 yet little is known about Ixodid ticks
in Hong Kong. It is not known whether this first
reported case of Lyme disease is due to a local
infection or not. However, the clinical
manifestations together with a seropositive rising
titre of antibody to Borrelia burgdorferi by IFA has
already met the criteria for national reporting of
Lyme disease in the United States.43 The
Department of Health of the Hong Kong
Government has confirmed with the authors that
no cases of Lyme disease have been reported in
Hong Kong61 and, therefore, we consider the
present investigation to be the first. The possible
reservoirs of the vectors for the spirochete -
Borrelia burgdorferi - are now being studied.
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